|
Name |
2H-pyran-2-one, 6-[(1S)-1-hydroxypropyl]-4-methoxy-5-methyl-
|
Molecular Formula | C10H14O4 | |
IUPAC Name* |
6-[(1S)-1-hydroxypropyl]-4-methoxy-5-methylpyran-2-one
|
|
SMILES |
CC[C@@H](C1=C(C(=CC(=O)O1)OC)C)O
|
|
InChI |
InChI=1S/C10H14O4/c1-4-7(11)10-6(2)8(13-3)5-9(12)14-10/h5,7,11H,4H2,1-3H3/t7-/m0/s1
|
|
InChIKey |
PMAGWBXRCQWPNQ-ZETCQYMHSA-N
|
|
Synonyms |
Annularin A; CHEMBL4556749; 2H-pyran-2-one, 6-[(1S)-1-hydroxypropyl]-4-methoxy-5-methyl-; 628302-54-5; DTXSID90348423; BDBM50523728; 6-(1-Hydroxy-propyl)-4-methoxy-5-methyl-pyran-2-one; 6-(1-hydroxypropyl)-4-methoxy-5-methyl-2H-pyran-2-one
|
|
CAS | 628302-54-5 | |
PubChem CID | 637272 | |
ChEMBL ID | CHEMBL4556749 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 198.22 | ALogp: | 0.4 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 55.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 14 | QED Weighted: | 0.805 |
Caco-2 Permeability: | -4.778 | MDCK Permeability: | 0.00002760 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.471 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.314 |
Blood-Brain-Barrier Penetration (BBB): | 0.371 | Plasma Protein Binding (PPB): | 59.26% |
Volume Distribution (VD): | 0.945 | Fu: | 37.58% |
CYP1A2-inhibitor: | 0.356 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.071 | CYP2C19-substrate: | 0.854 |
CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.577 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.656 |
CYP3A4-inhibitor: | 0.011 | CYP3A4-substrate: | 0.416 |
Clearance (CL): | 10.1 | Half-life (T1/2): | 0.81 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.616 |
Drug-inuced Liver Injury (DILI): | 0.323 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0.051 | Maximum Recommended Daily Dose: | 0.176 |
Skin Sensitization: | 0.151 | Carcinogencity: | 0.164 |
Eye Corrosion: | 0.022 | Eye Irritation: | 0.254 |
Respiratory Toxicity: | 0.094 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001982 | 0.674 | D02XJY | 0.265 | ||||
ENC005632 | 0.640 | D09GYT | 0.262 | ||||
ENC005633 | 0.600 | D0FA2O | 0.254 | ||||
ENC003474 | 0.569 | D0E9CD | 0.241 | ||||
ENC004939 | 0.510 | D0L5FY | 0.234 | ||||
ENC005634 | 0.481 | D0G4KG | 0.233 | ||||
ENC003262 | 0.471 | D05QDC | 0.232 | ||||
ENC004941 | 0.462 | D06REO | 0.231 | ||||
ENC003311 | 0.459 | D0B1IP | 0.230 | ||||
ENC005954 | 0.453 | D08VYV | 0.230 |